Cargando…

Layered and integrated medical countermeasures against Burkholderia pseudomallei infections in C57BL/6 mice

Burkholderia pseudomallei, the gram-negative bacterium that causes melioidosis, is notoriously difficult to treat with antibiotics. A significant effort has focused on identifying protective vaccine strategies to prevent melioidosis. However, when used as individual medical countermeasures both anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klimko, Christopher P., Shoe, Jennifer L., Rill, Nathaniel O., Hunter, Melissa, Dankmeyer, Jennifer L., Talyansky, Yuli, Schmidt, Lindsey K., Orne, Caitlyn E., Fetterer, David P., Biryukov, Sergei S., Burtnick, Mary N., Brett, Paul J., DeShazer, David, Cote, Christopher K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432870/ https://www.ncbi.nlm.nih.gov/pubmed/36060756 http://dx.doi.org/10.3389/fmicb.2022.965572

Ejemplares similares

Efficacy of Treatment with the Antibiotic Novobiocin against Infection with Bacillus anthracis or Burkholderia pseudomallei
por: Klimko, Christopher P., et al.
Publicado: (2022)

Evaluation of two different vaccine platforms for immunization against melioidosis and glanders
por: Biryukov, Sergei S., et al.
Publicado: (2022)

Deletion of Two Genes in Burkholderia pseudomallei MSHR668 That Target Essential Amino Acids Protect Acutely Infected BALB/c Mice and Promote Long Term Survival
por: Amemiya, Kei, et al.
Publicado: (2019)

Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice
por: Bearss, Jeremy J., et al.
Publicado: (2017)

Predictive and Experimental Immunogenicity of Burkholderia Collagen-like Protein 8-Derived Antigens
por: Grund, Megan E., et al.
Publicado: (2021)

Functional assays to screen and select monoclonal antibodies that target Yersinia pestis
por: Biryukov, Sergei S., et al.
Publicado: (2023)

Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies
por: Parthasarathy, Narayanan, et al.
Publicado: (2006)

Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei
por: Trevino, Sylvia R., et al.
Publicado: (2018)

Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model
por: Trevino, Sylvia R., et al.
Publicado: (2021)

The Chemical Arsenal of Burkholderia pseudomallei Is Essential for Pathogenicity
por: Biggins, John B., et al.
Publicado: (2014)

DBSecSys 2.0: a database of Burkholderia mallei and Burkholderia pseudomallei secretion systems
por: Memišević, Vesna, et al.
Publicado: (2016)

The Madagascar hissing cockroach as a novel surrogate host for Burkholderia pseudomallei, B. mallei and B. thailandensis
por: Fisher, Nathan A, et al.
Publicado: (2012)

A DUF4148 family protein produced inside RAW264.7 cells is a critical Burkholderia pseudomallei virulence factor
por: Welkos, Susan, et al.
Publicado: (2020)

Development of Melioidosis Subunit Vaccines Using an Enzymatically Inactive Burkholderia pseudomallei AhpC
por: Schmidt, Lindsey K., et al.
Publicado: (2022)

The Use of Analgesics during Vaccination with a Live Attenuated Yersinia pestis Vaccine Alters the Resulting Immune Response in Mice
por: Culbreth, Marilynn J., et al.
Publicado: (2019)

Protection Elicited by Attenuated Live Yersinia pestis Vaccine Strains against Lethal Infection with Virulent Y. pestis
por: Cote, Christopher K., et al.
Publicado: (2021)

Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague
por: Biryukov, Sergei S., et al.
Publicado: (2023)

Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the Yersinia pestis Plague rF1V Vaccine
por: Biryukov, Sergei, et al.
Publicado: (2021)

φX216, a P2-like bacteriophage with broad Burkholderia pseudomallei and B. mallei strain infectivity
por: Kvitko, Brian H, et al.
Publicado: (2012)

Management of Accidental Laboratory Exposure to Burkholderia pseudomallei and B. mallei
por: Peacock, Sharon J., et al.
Publicado: (2008)

The Burkholderia pseudomallei hmqA-G Locus Mediates Competitive Fitness against Environmental Gram-Positive Bacteria
por: Mou, Sherry, et al.
Publicado: (2021)

A type IVB pilin influences twitching motility and in vitro adhesion to epithelial cells in Burkholderia pseudomallei
por: Okaro, Udoka, et al.
Publicado: (2022)

Genomic patterns of pathogen evolution revealed by comparison of Burkholderia pseudomallei, the causative agent of melioidosis, to avirulent Burkholderia thailandensis
por: Yu, Yiting, et al.
Publicado: (2006)

Interrogation of the Burkholderia pseudomallei Genome to Address Differential Virulence among Isolates
por: Challacombe, Jean F., et al.
Publicado: (2014)

Activation of Toll-Like Receptors by Live Gram-Negative Bacterial Pathogens Reveals Mitigation of TLR4 Responses and Activation of TLR5 by Flagella
por: Amemiya, Kei, et al.
Publicado: (2021)

Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice
por: Bernhards, R. C., et al.
Publicado: (2016)

Burkholderia mallei and Burkholderia pseudomallei Cluster 1 Type VI Secretion System Gene Expression Is Negatively Regulated by Iron and Zinc
por: Burtnick, Mary N., et al.
Publicado: (2013)

A high-content imaging assay for the quantification of the Burkholderia pseudomallei induced multinucleated giant cell (MNGC) phenotype in murine macrophages
por: Pegoraro, Gianluca, et al.
Publicado: (2014)

Immune response to recombinant Burkholderia pseudomallei FliC
por: Koosakulnirand, Sirikamon, et al.
Publicado: (2018)

Dysregulation of TNF-α and IFN-γ expression is a common host immune response in a chronically infected mouse model of melioidosis when comparing multiple human strains of Burkholderia pseudomallei
por: Amemiya, Kei, et al.
Publicado: (2020)

Development of Immunoassays for Burkholderia pseudomallei Typical and Atypical Lipopolysaccharide Strain Typing
por: Nualnoi, Teerapat, et al.
Publicado: (2017)

An Objective Approach for Burkholderia pseudomallei Strain Selection as Challenge Material for Medical Countermeasures Efficacy Testing
por: Van Zandt, Kristopher E., et al.
Publicado: (2012)

Genomic Characterization of Burkholderia pseudomallei Isolates Selected for Medical Countermeasures Testing: Comparative Genomics Associated with Differential Virulence
por: Sahl, Jason W., et al.
Publicado: (2015)

Laser Scanning Confocal Microscopy Was Used to Validate the Presence of Burkholderia pseudomallei or B. mallei in Formalin-Fixed Paraffin Embedded Tissues
por: Amemiya, Kei, et al.
Publicado: (2020)

An increase in intracellular p62/NBR1 and persistence of Burkholderia mallei and B. pseudomallei in infected mice linked to autophagy deficiency
por: Saikh, Kamal U., et al.
Publicado: (2018)

Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays
por: Welkos, Susan L., et al.
Publicado: (2015)

The BALB/c Mouse Model for the Evaluation of Therapies to Treat Infections with Aerosolized Burkholderia pseudomallei
por: Nelson, Michelle, et al.
Publicado: (2023)

Tandem repeat regions within the Burkholderia pseudomallei genome and their application for high resolution genotyping
por: U'Ren, Jana M, et al.
Publicado: (2007)

The innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection
por: Koo, Ghee Chong, et al.
Publicado: (2006)

Development of Rapid Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Burkholderia pseudomallei
por: Suttisunhakul, Vichaya, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5at8itlnajkjitm7feqi4gdjdu